Ongoing studies on non-Hodgkin's lymphomas (NHL) within the EORTC lymphoma group

Oxygen-ozone action on Isaac's syndrome: a case report.

European review for medical and pharmacological sciences·2026

Oxygen-ozone autohemotherapy in breast cancer patients suffering from fatigue and musculoskeletal pain upon aromatase inhibitors treatment: a case-series study.

European review for medical and pharmacological sciences·2023

Lung cancer and COVID-19: problems and perspectives.

European review for medical and pharmacological sciences·2023

New treatment strategies for HIV-positive cancer patients undergoing anticancer medical treatment: update of the literature.

European review for medical and pharmacological sciences·2023

Fibromyalgia treated with oxygen-ozone auto-haemotherapy (O2-O3-AHT): a case study on 200 patients with a modified 10-PI-NRS evaluation.

European review for medical and pharmacological sciences·2022

Improved Survival and Quality of Life Through an Integrative, Multidisciplinary Oncological Approach: Pathophysiological Analysis of Four Clinical Cancer Cases and Review of the Literature.

Frontiers in pharmacology·2022

mTORC1 inhibition upregulates CD20 and enhances anti-CD20 antibody efficacy in B-cell precursor acute lymphoblastic leukemia.

Leukemia·2026

A novel role for transcription factor NFE2 in redox regulation and chemotherapy resistance in acute myeloid leukemia.

Leukemia·2026

Immunotherapeutic targeting of calreticulin mutant myeloproliferative neoplasms.

Leukemia·2026

A role for the protease MALT1 in EBV-mediated B-cell transformation by Latent Membrane Proteins 1 and 2.

Leukemia·2026

USP8 controls proteostasis pathways in B cells and multiple myeloma.

Leukemia·2026

The FOLR2-IRF2BP2 axis mediates erythropoiesis impairment by excess folic acid in myelodysplastic neoplasms.

Leukemia·2026

Fixed-duration epcoritamab plus R-CHOP in newly diagnosed LBCL with IPI score 3-5: results from the EPCORE NHL-2 trial.

Blood·2026

Utility of multiparametric flow cytometry in the diagnosis and staging of Classic Hodgkin lymphoma-Experience in real-world practice.

Cytometry. Part B, Clinical cytometry·2026

Genetic thrombophilia in cancer-associated thrombosis: the fly plowing with the ox or an old player's new role?

Haematologica·2026

Making remissions last: the promise of maintenance in primary central nervous system lymphoma.

Haematologica·2026

Venetoclax combined with high-dose cytarabine and mitoxantrone for relapsed or refractory acute myeloid leukemia: outcomes and risk stratification.

Haematologica·2026

The many faces (and phenotypes) of BCR::ABL1-driven acute leukemia.

Haematologica·2026

Related Experiment Videos

Ongoing studies on non-Hodgkin's lymphomas (NHL) within the EORTC lymphoma group

Related Concept Videos

Oxygen-ozone action on Isaac's syndrome: a case report.

Oxygen-ozone autohemotherapy in breast cancer patients suffering from fatigue and musculoskeletal pain upon aromatase inhibitors treatment: a case-series study.

Lung cancer and COVID-19: problems and perspectives.

New treatment strategies for HIV-positive cancer patients undergoing anticancer medical treatment: update of the literature.

Fibromyalgia treated with oxygen-ozone auto-haemotherapy (O2-O3-AHT): a case study on 200 patients with a modified 10-PI-NRS evaluation.

Improved Survival and Quality of Life Through an Integrative, Multidisciplinary Oncological Approach: Pathophysiological Analysis of Four Clinical Cancer Cases and Review of the Literature.

mTORC1 inhibition upregulates CD20 and enhances anti-CD20 antibody efficacy in B-cell precursor acute lymphoblastic leukemia.

A novel role for transcription factor NFE2 in redox regulation and chemotherapy resistance in acute myeloid leukemia.

Immunotherapeutic targeting of calreticulin mutant myeloproliferative neoplasms.

A role for the protease MALT1 in EBV-mediated B-cell transformation by Latent Membrane Proteins 1 and 2.

USP8 controls proteostasis pathways in B cells and multiple myeloma.

The FOLR2-IRF2BP2 axis mediates erythropoiesis impairment by excess folic acid in myelodysplastic neoplasms.

Fixed-duration epcoritamab plus R-CHOP in newly diagnosed LBCL with IPI score 3-5: results from the EPCORE NHL-2 trial.

Utility of multiparametric flow cytometry in the diagnosis and staging of Classic Hodgkin lymphoma-Experience in real-world practice.

Genetic thrombophilia in cancer-associated thrombosis: the fly plowing with the ox or an old player's new role?

Making remissions last: the promise of maintenance in primary central nervous system lymphoma.

Venetoclax combined with high-dose cytarabine and mitoxantrone for relapsed or refractory acute myeloid leukemia: outcomes and risk stratification.

The many faces (and phenotypes) of BCR::ABL1-driven acute leukemia.

Related Experiment Videos

Ongoing studies on non-Hodgkin's lymphomas (NHL) within the EORTC lymphoma group

Related Concept Videos

Related Articles